1/19
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Diabetic Ketoacidosis (DKA)
Reduced effective insulin + increased counterregulatory hormones leading to:
+ Hyperglycemia as a result of:
- Increased gluconeogenesis
- Accelerated glycogenolysis
- Impaired glucose utilization by tissues
+ Ketosis as a result of:
- Lipolysis from adipose tissues
- Hepatic fatty acid oxidation to ketone bodies (ß hydroxybutyrate, acetoacteate)
Hyperosmolar Hyperglycemic State (HHS)
Relative insulin deficiency + increased counterregulatory hormones leading to:
+ Hyperglycemia
- Causes osmotic diuresis, dehydration, and impaired renal function
+ Hyperosmolarity:
- Increased intravascular osmolarity
**Insulin levels in HHS are sufficient to prevent lipolysis**
Diabetic Ketoacidosis (DKA) Precipitating Factors
- New onset DM type 1
- Omitting Insulin
- Acute Illness
- Infection
Diabetic Ketoacidosis (DKA) Onset
Rapid (Hours to Days)
Diabetic Ketoacidosis (DKA) Clinical Presentation
- Abdominal pain, Nausea, Vomiting
- Dehydration
- Kussmaul Respirations (Deep, rapid respirations)
- Possible altered mental status
Hyperosmolar Hyperglycemic State (HHS) Precipitating Factors
• Prolonged hyperglycemia (more common in older patients with DM Type 2)
• Acute illness
• Infection
Hyperosmolar Hyperglycemic State (HHS) Onset
Days to weeks
Hyperosmolar Hyperglycemic State (HHS) Clinical Presentation
• Polyuria (Urination)
• Polydipsia (Thirst)
• Fatigue, weakness
• Dehydration
• Possible altered mental status
Euglycemic diabetic ketoacidosis (EDKA) Labs
• Euglycemia (serum glucose <250 mg/dL)
• Metabolic acidosis (serum bicarbonate <18 mEq/L and pH < 7.3)
• Ketosis
What class of oral medications have increased the recognition & incidence of EDKA in recent years?
SGLT2i
Hyperosmolar Hyperglycemic State (HHS) Glucose
> 600
Low arterial pH < 7.3 & Low sodium bicarbonate < 18 indicates
Diabetic Ketoacidosis
Fluid Replacement for DKA & HHS
Isotonic saline (0.9% NaCl) bolus:
+ 500-1000 ml/hr x 2-4 hrs, followed by:
- 9% NaCl 250-500 ml/hr infusion,
OR
- 0.45% NaCl 250-500 ml/hr infusion
+ Once serum glu is < 200 mg/dL for DKA or < 300 mg/dL for HHS:
Change to 5% dextrose/0.45% NaCl @ 150-250 ml/hr
+ Rationale:
Most patients will have major fluid deficits
IV Fluids: Expand intravascular volume, restore renal perfusion, & reduce insulin resistance by decreasing counter-regulatory hormones
Bicarbonate use in DKA
** DKA ONLY, to correct acidosis
+ Only indicated if pH < 6.9
+ Dose:
Sodium Bicarbonate 50-100 mmol (50-100 mEq) as on isotonic solution
- Example: 100 mmol (mEq) in 400 ml sterile water over 2 hrs
- Example: 50-150 mmol (mEq) in 1000 ml D5W over 1-1.5 hrs
- Repeat every 2 hrs until pH > 7
Goal glucose reduction for DKA & HHS
~ 50-75 mg/dl/hr
- Avoid overly rapid correction
Transition to maintenance insulin regimen for DKA & HHS when:
• Glucose < 250 mg/dL
• pH > 7.3 (DKA)
• Serum bicarbonate > 18 mEq/L (DKA)
• Serum Osmolality < 310 mOsm/kg (HHS)
• Mental status changes improved (if applicable)
EDKA Insulin Considerations
+ Start insulin at a rate of 0.05 - 0.1 units/kg/h for management of ketosis PLUS
+ Co-administer IV dextrose 5% infusion
If Potassium < ______ mEq/L, Hold Insulin & give ________
3.3
KCl 20 - 30 mEq/hr until K > 3.3
Goal K
4-5 mEq/L
• Check every 2 hrs
What do we do if Potassium 3.3 - 5.2
Start Insulin
+ Give KCl 20 - 30 mEq/L of IVF